2246607-08-7 ((Inupadenant)

HQ700V0X06;Inupadenant;Inupadenant [INN];Inupadenant [USAN];EOS100850;WHO 11380;Thiazolo(5,4-E)(1,2,4)triazolo(1,5-C)pyrimidin-2(3H)-one, 5-amino-3-(2-(4-(2,4-difluoro-5-(2-((S)-methylsulfinyl)ethoxy)phenyl)-1-piperazinyl)ethyl)-8-(2-furanyl)-;Thiazolo(5,4-E)(1,2,4)triazolo(1,5-C)pyrimidin-2(3H)-one, 5-amino-3-(2-(4-(2,4-difluoro-5-(2-(methylsulfinyl)ethoxy)phenyl)-1-piperazinyl)ethyl)-8-(2-furanyl;7-amino-10-[2-[4-[2,4-difluoro-5-[2-[(S)-methylsulfinyl]ethoxy]phenyl]piperazin-1-yl]ethyl]-4-(furan-2-yl)-12-thia-3,5,6,8,10-pentazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7-tetraen-11-one;EX-A7371;2246607-08-7;SCHEMBL20521605;HY-137442;EOS 100850;UNII-HQ700V0X06;EOS-100850;CHEMBL4650331;MS-30655;EOS-850;G18108;GLXC-26874;Thiazolo(5,4-E)(1,2,4)triazolo(1,5-C)pyrimidin-2(3H)-one, 5-amino-3-(2-(4-(2,4-difluoro-5-(2-(methylsulfinyl)ethoxy)phenyl)-1-piperazinyl)ethyl)-8-(2-furanyl)-, (+)-;(+)-5-AMINO-3-(2-(4-(2,4-DIFLUORO-5-(2-((S)-METHANESULFINYL)ETHOXY)PHENYL)PIPERAZIN-1-YL)ETHYL)-8-(FURAN-2-YL)THIAZOLO(5,4-E)(1,2,4)TRIAZOLO(1,5-C)PYRIMIDIN-2(3H)-ONE;INUPADENANT [WHO-DD];(+)-5-AMINO-3-(2-(4-(2,4-DIFLUORO-5-(2-((S)-METHANESULFINYL)ETHOXY)PHENYL)PIPERAZIN-1- YL)ETHYL)-8-(FURAN-2-YL)THIAZOLO(5,4-E)(1,2,4)TRIAZOLO(1,5-C)PYRIMIDIN-2(3H)-ONE;Inupadenant [USAN:INN];A2A Receptor Antagonist EOS100850;CS-0138645;

QYCCLUSYHJXDEX-RWYGWLOXSA-N

1S/C25H26F2N8O4S2/c1-41(37)12-11-39-19-14-17(15(26)13-16(19)27)33-7-4-32(5-8-33)6-9-34-22-20(40-25(34)36)23-29-21(18-3-2-10-38-18)31-35(23)24(28)30-22/h2-3,10,13-14H,4-9,11-12H2,1H3,(H2,28,30)/t41-/m0/s1

S1C(N(C2=C1C1=NC(C3=CC=CO3)=NN1C(N)=N2)CCN1CCN(C2C(=CC(=C(C=2)OCC[S@](C)=O)F)F)CC1)=O